Insulet (PODD) P/S ratio

P/S ratio today
3.9×

Insulet (PODD) trades at 3.9× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 7.5×. That is 19.0% lower than the 9.3× of fiscal 2024. Figures as of 18 Nov 2026, 07:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
3.9×
P/S ratio, fiscal 2025
7.5×
Change on fiscal 2024
−19.0%
Highest on record
18.6×fiscal 2020
Lowest on record
5.9×fiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Insulet P/S ratio, in more detail

Today's figure is 48.9% below the fiscal 2025 year-end.

Across the 10 fiscal year-ends on record (2016–2025), the highest was 18.6× in fiscal 2020 and the lowest 5.9× in fiscal 2016. Today's P/S ratio is at or below every one of the 10 fiscal year-ends on record; their median is 9.4×.

History · 10 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Insulet P/S ratio, year by year

Insulet (PODD) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today3.9×—$145.34—
20257.5× 19.0% down$284.24$37.67
20249.3× 1.1% down$261.07$28.04
20239.4× 40.3% down$216.98$23.05
202215.8× 10.1% down$294.39$18.67
202117.5× 5.9% down$266.07$15.17
202018.6× 29.0% up$255.63$13.71
201914.4× 68.3% up$171.20$11.85
20188.6× 0.5% down$79.32$9.24
20178.6× 46.8% up$69.00$8.00
20165.9×—$37.68$6.41
2015——$37.81—
2014——$46.06—
2013——$37.10—
2012——$21.22—
2011——$18.83—
2010——$15.50—
2009——$14.28—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Insulet and comparable companies
CompanyP/S ratio
Bio-Rad Laboratories BIO3.7×
Molina Healthcare MOH0.3×
Qiagen QGEN4.9×
Insulet PODD3.7×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on PODD

Insulet, figure by figure

Insulet (PODD) overview: price, valuation and scorecardAll health care companies by market value

Insulet P/S ratio: questions and answers

What is Insulet's P/S ratio?

Insulet (PODD) trades at 3.9× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 7.5×. That is 19.0% lower than the 9.3× of fiscal 2024.

Is Insulet's P/S ratio high or low compared with its own history?

Today's P/S ratio is at or below every one of the 10 fiscal year-ends on record; their median is 9.4×.

What are the highest and lowest P/S ratio figures on record for Insulet?

Across the 10 fiscal year-ends on record (2016–2025), the highest was 18.6× in fiscal 2020 and the lowest 5.9× in fiscal 2016.

How is Insulet's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insulet (PODD) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/PODD/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.